Vestal Point Capital’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-425,000	Closed	-$2.95M	–	69
2024 Q4	$2.95M	Sell	425,000 -505,000	-54%	-$3.5M	0.17%	63
2024 Q3	$4.93M	Buy	930,000 +40,000	+4%	+$212K	0.37%	47
2024 Q2	$3.33M	Buy	+890,000	New	+$3.33M	0.25%	50